Health · 2 views
RSV admissions among infants fall sharply following vaccine rollout
While most experience mild symptoms, the virus can cause severe breathing difficulties in newborns and young infants and may require hospital treatment.
AI Summary
Hospital admissions for respiratory syncytial virus (RSV) in infants have dropped sharply after the introduction of a maternal vaccine program. The vaccine has been offered to pregnant women in Denmark since the fall of 2025 to protect newborns during their first months of life. The decline follows the rollout of this preventive measure, indicating a rapid impact on severe RSV cases that previously required hospital treatment.
Read full article on Medical XpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Hospitals could track emissions, water and waste alongside patient safetyContinue reading
- Now is the time for evidence-based, specific dietary guidance to nourish adolescentsContinue reading
- Reserchers confirm cost-effectiveness of mass hepatitis C virus screening among persons in custody in Hong KongContinue reading
- 22 million human immune cells help decode context-dependent gene circuitsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow